Home Sulfos 2-Chloro-5-(2H-tetrazol-5-yl)-4-((thiophen-2-ylmethyl)amino)benzenesulfonamide

2-Chloro-5-(2H-tetrazol-5-yl)-4-((thiophen-2-ylmethyl)amino)benzenesulfonamide

CAS No.:
27589-33-9
Catalog Number:
AG002U6L
Molecular Formula:
C12H11ClN6O2S2
Molecular Weight:
370.8377
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
25mg
98%(HPLC)
In Stock USA
United States
$155
- +
100mg
98%(HPLC)
In Stock USA
United States
$433
- +
1g
98%(HPLC)
In Stock USA
United States
$1261
- +
Product Description
Catalog Number:
AG002U6L
Chemical Name:
2-Chloro-5-(2H-tetrazol-5-yl)-4-((thiophen-2-ylmethyl)amino)benzenesulfonamide
CAS Number:
27589-33-9
Molecular Formula:
C12H11ClN6O2S2
Molecular Weight:
370.8377
MDL Number:
MFCD00867321
IUPAC Name:
2-chloro-5-(2H-tetrazol-5-yl)-4-(thiophen-2-ylmethylamino)benzenesulfonamide
InChI:
InChI=1S/C12H11ClN6O2S2/c13-9-5-10(15-6-7-2-1-3-22-7)8(12-16-18-19-17-12)4-11(9)23(14,20)21/h1-5,15H,6H2,(H2,14,20,21)(H,16,17,18,19)
InChI Key:
HMEDEBAJARCKCT-UHFFFAOYSA-N
SMILES:
Clc1cc(NCc2cccs2)c(cc1S(=O)(=O)N)c1n[nH]nn1
EC Number:
248-549-7
UNII:
MR40VT1L8Z
Properties
Complexity:
504  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
370.007g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
370.83g/mol
Monoisotopic Mass:
370.007g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
163A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  
Literature
Title Journal
Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF). Journal of cardiology 20120501
Comparative evaluation of two isobaric labeling tags, DiART and iTRAQ. Analytical chemistry 20120320
Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure. Circulation journal : official journal of the Japanese Circulation Society 20120101
Amine metabolomics of hyperglycemic endothelial cells using capillary LC-MS with isobaric tagging. Journal of proteome research 20111104
Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy. European journal of heart failure 20110801
Deuterium isobaric amine-reactive tags for quantitative proteomics. Analytical chemistry 20100915
Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide. Journal of cardiovascular pharmacology 20090601
Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs. American journal of veterinary research 20081201
Chronic heart failure in Japan: implications of the CHART studies. Vascular health and risk management 20080201
The effect of retinoic acid on a zinc finger transcription factor, AJ18, during differentiation of a rat clonal preosteoblastic cell line, ROB-C20, into osteoblasts. Archives of oral biology 20080101
Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC). Circulation journal : official journal of the Japanese Circulation Society 20070701
Mechanism of enhanced bioavailability and diuretic effect of azosemide by ascorbic acid in rats. Life sciences 20060202
Functional characterization of human monocarboxylate transporter 6 (SLC16A5). Drug metabolism and disposition: the biological fate of chemicals 20051201
Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. Cardiovascular research 20051001
[Efficacy and safety of azosemide in patients with edema and ascites]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20050901
Increase in intracellular Cl- concentration by cAMP- and Ca2+-dependent stimulation of M1 collecting duct cells. Pflugers Archiv : European journal of physiology 20050201
Pharmacokinetics and pharmacodynamics of azosemide. Biopharmaceutics & drug disposition 20031001
Expression and regulation of the Na+-K+-2Cl- cotransporter NKCC1 in the normal and CFTR-deficient murine colon. The Journal of physiology 20030601
Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats. Drug metabolism and disposition: the biological fate of chemicals 20030201
Influence of 4-week and 8-week exercise training on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats. Life sciences 20020329
Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure. Journal of cardiovascular pharmacology 20011001
Human atrial natriuretic peptide is a useful criterion in treatment of nocturia. Scandinavian journal of urology and nephrology 20010901
Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition. Life sciences 20010413
No effect of cysteine on the pharmacokinetics of intravenous azosemide in rats with protein-calorie malnutrition by pretreatment with 3-methylcholanthrene. Research communications in molecular pathology and pharmacology 20010101
Quantitative evaluation of ototoxic side effects of furosemide, piretanide, bumetanide, azosemide and ozolinone in the cat--a new approach to the problem of ototoxicity. Naunyn-Schmiedeberg's archives of pharmacology 19851101
Properties